{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:22:15Z","timestamp":1777382535598,"version":"3.51.4"},"reference-count":32,"publisher":"Publicidad Permanyer, SLU","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Cardiolog\u00eda de M\u00e9xico"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.acmx.2016.01.007","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T09:00:36Z","timestamp":1457514036000},"page":"297-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of clopidogrel response variability and identification of the CYP2C19 polymorphism in Mexican patients"],"prefix":"10.24875","volume":"86","author":[{"given":"Martha Eva","family":"Viveros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Are\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soledad","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Humberto","family":"Cardiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Taboada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gissela","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Solorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalley","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10499","reference":[{"key":"10.1016\/j.acmx.2016.01.007_bib0165","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/CIRCULATIONAHA.107.181940","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.acmx.2016.01.007_bib0170","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2006.06.049","article-title":"Benefit of a 600mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST elevation acute coronary syndrome undergoing coronary stenting","volume":"48","author":"Cuisset","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acmx.2016.01.007_bib0175","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S0049-3848(11)70017-2","article-title":"Resistance to antiplatelet agents","volume":"127","author":"Cattaneo","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.acmx.2016.01.007_bib0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2796.2002.01027.x","article-title":"Individual variations of platelet inhibition after loading doses of clopidogrel","volume":"252","author":"J\u00e4remo","year":"2002","journal-title":"J Intern Med"},{"key":"10.1016\/j.acmx.2016.01.007_bib0185","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acmx.2016.01.007_bib0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1160\/TH09-03-0185","article-title":"Clopidogrel response variability; current status and future directions","volume":"102","author":"Ferreiro","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acmx.2016.01.007_bib0195","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0002-9149(02)02471-2","article-title":"Effect of loading with clopidogrel at the time of coronary stenting on platelet aggregation and glycoprotein IIb\/IIIa expression and platelet-leukocyte aggregate formation","volume":"90","author":"Gurbel","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acmx.2016.01.007_bib0200","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1067\/mhj.2003.109","article-title":"Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial. Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial","volume":"145","author":"Gurbel","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.acmx.2016.01.007_bib0205","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.acmx.2016.01.007_bib0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1538-7836.2004.01063.x","article-title":"Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases","volume":"3","author":"Aleil","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acmx.2016.01.007_bib0215","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.jacc.2007.07.051","article-title":"Platelet function monitoring in patients with coronary artery disease","volume":"50","author":"Gurbel","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acmx.2016.01.007_bib0220","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fgene.2012.00318","article-title":"Clinical application of CYP2C19 pharmacogenetics toward more personalized medicine","volume":"3","author":"Lee","year":"2013","journal-title":"Front Genet"},{"key":"10.1016\/j.acmx.2016.01.007_bib0225","first-page":"125","article-title":"Allele frequency of CYP2C19 gene polymorphisms in healthy Iranian population","volume":"4","author":"Zand","year":"2005","journal-title":"Iran J Pharmacol Ther"},{"key":"10.1016\/j.acmx.2016.01.007_bib0230","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2133\/dmpk.20.300","article-title":"Variations and haplotypes of CYP2C19 in Japanese population","volume":"20","author":"Fukushima-Uesaka","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.acmx.2016.01.007_bib0235","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACC\/AHA\/SCAI Guidelines for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acmx.2016.01.007_bib0240","series-title":"Molecular cloning a laboratory manual","author":"Sambrook","year":"2001"},{"key":"10.1016\/j.acmx.2016.01.007_bib0245","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/hrt.2010.195438","article-title":"Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"97","author":"Siller-Matula","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.acmx.2016.01.007_bib0250","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.acmx.2016.01.007_bib0255","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/eurheartj\/ehl275","article-title":"Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation","volume":"27","author":"Geisler","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acmx.2016.01.007_bib0260","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ccd.10497","article-title":"Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation","volume":"59","author":"Barragan","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.acmx.2016.01.007_bib0265","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1538-7836.2007.02609.x","article-title":"Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events","volume":"5","author":"George","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acmx.2016.01.007_bib0270","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1160\/TH07-05-0324","article-title":"The significance of vasodilator stimulated phosphoprotein for risk stratification of stent thrombosis","volume":"98","author":"Blindt","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acmx.2016.01.007_bib0275","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Consensus and future directions on the definition of high on treatment platelet reactivity to adenosine diphosphate","volume":"56","author":"Bonello","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acmx.2016.01.007_bib0280","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.amjcard.2008.08.048","article-title":"Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis","volume":"103","author":"Bonello","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acmx.2016.01.007_bib0285","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.thromres.2006.08.012","article-title":"Clopidogrel resistance","volume":"120","author":"Gurbel","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.acmx.2016.01.007_bib0290","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1089\/gtmb.2012.0055","article-title":"Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico","volume":"16","author":"Salazar-Flores","year":"2012","journal-title":"Genet Test Mol Biomark"},{"key":"10.1016\/j.acmx.2016.01.007_bib0295","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clpt.2006.03.003","article-title":"Genetic polymorphism of cytochrome P450 2C19 in Mexican Americans; a cross-ethnic comparative study","volume":"80","author":"Luo","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.acmx.2016.01.007_bib0300","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6904-7-6","article-title":"Phenotype-genotype analysis of CYP2C19 in Colombians mestizo individuals","volume":"7","author":"Isaza","year":"2007","journal-title":"BMC Clin Pharmacol"},{"key":"10.1016\/j.acmx.2016.01.007_bib0305","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1182\/blood-2006-04-013052","article-title":"Cytochrome P450 2C19 loss-of-function polymorphismis a major determinantof clopidogrel responsiveness in healthy subjects","volume":"108","author":"Hulot","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.acmx.2016.01.007_bib0310","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome P 450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acmx.2016.01.007_bib0315","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/hrt.2010.220509","article-title":"Variability in on-treatment platelet reactivity explained by CYP2C19*2genotype is modest in clopidogrel pretreated patients undergoing coronary stenting","volume":"97","author":"Bouman","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.acmx.2016.01.007_bib0320","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1001\/jama.2011.1880","article-title":"CYP 2C19 genotype: clopidogrel metabolism, platelet function and cardiovascular events. A systematic review and meta-analysis","volume":"306","author":"Holmes","year":"2011","journal-title":"JAMA"}],"container-title":["Archivos de Cardiolog\u00eda de M\u00e9xico"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S140599401600029X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S140599401600029X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.archivoscardiologia.com\/previos\/(2016)%20ACM%20Vol%2086.%204%20OCTUBRE-DICIEMBRE\/ACMX_2016_86_4_297-304.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T06:43:11Z","timestamp":1567665791000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.archivoscardiologia.com\/previos\/(2016)%20ACM%20Vol%2086.%204%20OCTUBRE-DICIEMBRE\/ACMX_2016_86_4_297-304.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S140599401600029X"],"URL":"https:\/\/doi.org\/10.1016\/j.acmx.2016.01.007","relation":{},"ISSN":["1405-9940"],"issn-type":[{"value":"1405-9940","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of clopidogrel response variability and identification of the CYP2C19 polymorphism in Mexican patients","name":"articletitle","label":"Article Title"},{"value":"Archivos de Cardiolog\u00eda de M\u00e9xico","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acmx.2016.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}